Gunsynd (EVO)

 

EVO Share PerformanceMore

52 week high0.0000 29/09/16
52 week low0.0000 29/09/16
52 week change 0.0000 (0.00%)
4 week volume0 03/09/16

Latest NewsMore

Evocutis changes name to Gunsynd

Evocutis has been changed its name to Gunsynd. The company will trade under its new ticker, GUN, from 7 a.m. tomorro...

Change of Name

RNS Number: 1691G Evocutis PLC 03 August 2016 Evocutis plc ("Evocutis" or the "Company") Change of Name Evocutis (AIM: EVO, ISDX: EVO) announces that today the name of the Company has been changed to Gunsynd plc. As of 7am on 4 August 2016, the Company will adopt the ticker GUN. This announcement contains inside information for the purposes ...

Horse Hill Update

RNS Number: 5288E Evocutis PLC 19 July 2016 Evocutis Plc ("Evocutis" or the "Company") Upgrade to Portland Oil in Place, Horse Hill-1 Discovery, Weald Basin Evocutis (AIM: EVO, ISDX: EVO) announces that a new petrophysical analysis by Nutech, incorporating the findings of the successful Horse Hill-1 ("HH-1") flow test, demonstrates a threefold increase in ca...

Evocutis confirms Weald Basin licence conversion

Evocutis says the Oil and Gas Authority has granted a licence conversion to new model terms for Horse Hill PEDL137 and...

Key Licence Conversion, Weald Basin

RNS Number: 2131D Evocutis PLC 05 July 2016 Evocutis plc ("Evocutis" or the "Company") Key Licence Conversion, Kimmeridge and Portland Region, Weald Basin Evocutis (AIM: EVO, ISDX: EVO) is pleased to announce that the Oil and Gas Authority ("OGA") has granted a licence conversion to new model terms for Horse Hill ("HH") PEDL137 and PEDL246. A...

Evocutis strengthens its board

Evocutis has appointed Christopher Gordon as a non-executive director. Gordon has a Bachelor of Economics degree awar...

Directorate Change

RNS Number: 9690V Evocutis PLC 21 April 2016 Evocutis plc ("Evocutis" or the "Company") Board Appointment Evocutis (AIM: EVO, ISDX: EVO) announces that Christopher Gordon has been appointed to the board with immediate effect as a non-executive director. Christopher Gordon has a Bachelor of Economics degree awarded by the University of London a...

Evocutis losses widen

Evocutis has reported a net loss after taxation for the six months ended 31 January 2016 of GBP85,000 (2015 - GBP62,000 los...

Equity Research (EVO)

Evocutis plc
01/12/2014
Navigating the Lifesciences Labyrinth The lifesciences sector is often uncorrelated with market sentiment; with both defensive elements and high risk biotech binary plays sitting side by side in the...

Latest discussion posts More

  • Radio 4 this morning 27 July

    from Blue Mogganer Rem "There was a fairly upbeat item on their business news early this morning about Tesla's massive Gigabyte factory for production of lithium batteries ...
    27-Jul-2016
    sage in the hills
  • Tesla trigger for very great Lithium uptake

    Tesla has dropped price of cars, so this should create greater sales of cars, greater demand, and hence greater through-put of batteries... .... and hence greater demand ...
    26-Jul-2016
    sage in the hills
  • Extract from Interim Results for the six months ended 31 January 2016 PDF, 379.78 KB posted on 19th April. Investment in Brazil Tungsten Holdings Limited (?BTHL?): The ...
    13-Jul-2016
    ybhere

Users' HoldingsMore

Users who hold Gunsynd also hold..

Codes & Symbols

ISINGB00B4WKYH05
SymbolsEVO, LSE:EVO, EVO.L, EVO:LN, LON:EVO, XLON:EVO